Open Access DOI Assigned

Yoga-Based Lifestyle Intervention versus Pharmacological Management in Metabolic Syndrome: A Randomised Controlled Trial Assessing Glycaemic Control, Lipid Profiles, Anthropometric Indices

Volume 3, Issue 4

  • Author(s)Priya Ramachandran, Suresh Kumar Nair, Ananya Krishnamurthy
  • AffiliationDepartment of Medicine and Integrative Health Sciences, Marwar Medical University, Jodhpur
  • Page No.113-117
  • Volume, Issue & YearVolume 3, Issue 4, April 2026
  • Published On2026/04/21
  • JournalInternational Journal of Advanced Multidisciplinary Application (IJAMA)
  • ISSN No.3048-9350
  • DOIhttps://doi.org/10.5281/zenodo.19681994
Article Indexing

Abstract

Metabolic syndrome (MetS) affects approximately 33% of urban Indian adults and constitutes a primary driver of type 2 diabetes, cardiovascular disease, and non-alcoholic fatty liver disease in the Indian subcontinent. While pharmacological management with statins, metformin, and antihypertensives is standard of care, yoga-based lifestyle interventions have demonstrated promising preliminary effects on cardiometabolic risk factors in small uncontrolled studies. This twenty-four-week parallel-arm randomised controlled trial enrolled 312 urban adults (aged 30–60 years) with confirmed MetS by IDF criteria across three AIIMS-affiliated urban centres in Delhi-NCR. Participants were randomised to: Yoga-Based Lifestyle Intervention (YBLI, n=104), Pharmacological Management alone (PM, n=104), or Combined YBLI plus Pharmacological Management (YBLI+PM, n=104). Primary outcomes included fasting blood glucose, HbA1c, lipid panel (LDL-C, HDL-C, TG), waist circumference, and high-sensitivity C-reactive protein (hs-CRP). The YBLI+PM group achieved the greatest reductions in HbA1c (−1.8%, p<0.001), fasting glucose (−32.4 mg/dL), LDL-C (−28.6 mg/dL), and hs-CRP (−2.4 mg/L) compared to either intervention alone. YBLI alone produced clinically meaningful reductions in waist circumference (−6.2 cm) and triglycerides (−38.4 mg/dL), comparable to PM alone, suggesting yoga may serve as a safe and effective non-pharmacological alternative for early-stage MetS management. These findings support the integration of structured yoga programmes into standard MetS management protocols in Indian clinical settings

Keywords: metabolic syndrome, yoga intervention, glycaemic control, lipid profile, inflammatory biomarkers, urban India, randomised controlled trial, integrative medicine

References

  1. [1] Alberti, K. G., Zimmet, P., & Shaw, J. (2006). Metabolic syndrome—a new world-wide definition. Diabetic Medicine, 23(5), 469–480.
  2. [2] Bijlani, R. L., Vempati, R. P., Yadav, R. K., et al. (2005). A brief but comprehensive lifestyle education program based on yoga reduces risk factors for cardiovascular disease. Journal of Alternative and Complementary Medicine, 11(2), 267–274.
  3. [3] Chandrasekaran, B., Thiyagarajan, R., Anand, B., & Padmanabhan, V. (2018). Yoga for cardiometabolic diseases: A scoping review of literature. Indian Heart Journal, 70(6), 797–802.
  4. [4] Gupta, N., Goel, K., Shah, P., & Misra, A. (2012). Childhood obesity in developing countries: Epidemiology, determinants, and prevention. Endocrine Reviews, 33(1), 48–70.
  5. [5] ICMR-INDIAB Study Collaborative Group. (2017). Prevalence of metabolic syndrome in urban and rural India. National Medical Journal of India, 30(5), 240–247.
  6. [6] Innes, K. E., Bourguignon, C., & Taylor, A. G. (2005). Risk indices associated with insulin resistance syndrome and possible protection with yoga. Journal of the American Board of Family Practice, 18(6), 491–519.
  7. [7] Jain, S. C., Uppal, A., Bhatnagar, S. O. D., & Talukdar, B. (1993). A study of response pattern of non-insulin dependent diabetics to yoga therapy. Diabetes Research and Clinical Practice, 19(1), 69–74.
  8. [8] Malhotra, V., Singh, S., Tandon, O. P., & Sharma, S. B. (2005). The beneficial effect of yoga in diabetes. Nepal Medical College Journal, 7(2), 145–147.
  9. [9] Misra, A., & Khurana, L. (2009). The metabolic syndrome in South Asians: Epidemiology, determinants, and prevention. Metabolic Syndrome and Related Disorders, 7(6), 497–514.
  10. [10] Patil, S. G., Aithala, M. R., & Das, K. K. (2015). Effect of yoga on arterial stiffness in elderly subjects with increased pulse pressure. Complementary Therapies in Medicine, 23(4), 562–569.
  11. [11] Ramachandran, A., Snehalatha, C., & Ma, R. C. (2014). Diabetes in South-East Asia: An update. Diabetes Research and Clinical Practice, 103(2), 231–237.
  12. [12] Raveendran, A. V., Deshpandae, A., & Joshi, S. R. (2018). Therapeutic role of yoga in type 2 diabetes. Endocrinology and Metabolism (Seoul), 33(3), 307–317.
  13. [13] RSSDI-ESI Clinical Practice Recommendations for the Management of Type 2 Diabetes Mellitus 2020. International Journal of Diabetes in Developing Countries, 40(Suppl 1), 1–184.
  14. [14] Sharma, R., Gupta, N., & Bijlani, R. L. (2008). Effect of yoga based lifestyle intervention on subjective well-being. Indian Journal of Physiology and Pharmacology, 52(2), 123–131.
  15. [15] WHO. (2020). WHO Guidelines on Physical Activity and Sedentary Behaviour. World Health Organization, Geneva.

Explore Our Related Journals

Looking for the right journal for your next manuscript? Explore our international peer-reviewed journals covering engineering, management, computer science, artificial intelligence and multidisciplinary research.